Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV001335358 | SCV001528490 | uncertain significance | Myopathy, myofibrillar, 9, with early respiratory failure | 2018-11-27 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Revvity Omics, |
RCV003135995 | SCV003825602 | uncertain significance | not provided | 2022-06-16 | criteria provided, single submitter | clinical testing | |
Mayo Clinic Laboratories, |
RCV003135995 | SCV005413131 | uncertain significance | not provided | 2024-08-15 | criteria provided, single submitter | clinical testing | PM2 |
Ce |
RCV003135995 | SCV005436265 | uncertain significance | not provided | 2024-09-01 | criteria provided, single submitter | clinical testing | TTN: PM2, BP4 |